|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/427 | |
| C07D 487/04 | |||
| C07D 403/12 | |||
| C07D 207/09 |
| (11) | Number of the document | 2770996 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12844551.7 |
| Date of filing the European patent application | 2012-10-22 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/061252 |
| Date | 2012-10-22 |
| (87) | Number | WO 2013/062881 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161552195 P | 2011-10-27 | US |
| (72) |
YASUDA, Nobuyoshi, US
LIU, Zhuqing, US
ZHONG, Yong-Li, US
CHUNG, John Y., L., US
YASUDA, Nobuyoshi, US
MALONEY, Kevin, M., US
CAMPOS, Kevin, US
HOERRNER, R., Scott, US
LYNCH, Joseph, US
XU, Feng, US
CLEATOR, Edward, GB
GIBSON, Andrew, GB
KEEN, Stephen, GB
LIEBERMANN, Dave, GB
YOSHIKAWA, Naoki, JP
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES |
| PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES |